Evidence map›Paper›PMID 28789392›Full record

ArticleOncology letters2017

Association between protocadherin 8 promoter hypermethylation and the pathological status of prostate cancer.

Peng Zhang, Hui Wang, Jianming Wang, Qingzuo Liu, Yongqiang Wang, Fan Feng, Lei Shi

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Peng ZhangDepartment of Urology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.
Hui WangDepartment of Urology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.
Jianming WangDepartment of Urology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.
Qingzuo LiuDepartment of Urology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.
Yongqiang WangDepartment of Urology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.
Fan FengDepartment of Urology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.
Lei ShiDepartment of Urology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.
Yuhuangding Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Promoter hypermethylation of tumor suppressor genes has been confirmed to serve a pivotal role in tumorigenesis. Protocadherin 8 (

Indexed as

prognosispromoter hypermethylationprostate cancerprotocadherin 8

Identifiers

PMID28789392
PMCPMC5529879
OpenAlexW2618044316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.